Skip to main content
Log in

The synthetic retinoid Fenretinide does not affect circulating hormone concentrations

  • Correspondence
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton DL, Smith JM, Phillips SL, Henderson WR, Mullen LT, Brown CC, Sporn MB: N-(4-hydroxyphenyl)-retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 39: 1339–1346, 1979

    PubMed  Google Scholar 

  2. McCormick DL, Metha RG, Thompson CA, Dinger N, Caldwell JA, Moon RC: Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)-retinamide and ovariectomy. Cancer Res 42: 508–512, 1982

    PubMed  Google Scholar 

  3. McCormick DL, Moon RC: Retinoid-tamoxifen interaction in mammary cancer chemoprevention. Carcinogenesis 7: 193–196, 1986

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Secreto, G., Costa, A., Recchione, C. et al. The synthetic retinoid Fenretinide does not affect circulating hormone concentrations. Breast Cancer Res Tr 12, 315–316 (1988). https://doi.org/10.1007/BF01811246

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01811246

Keywords

Navigation